Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
Bruno Fattizzo(University of Milan), Austin Kulasekararaj(King's College London), Petra Muus(Radboud University Nijmegen), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Katy Sanchez(King's College Hospital), Dario Consonni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Deborah Yallop(King's College Hospital NHS Foundation Trust), Alan Dunlop(King's College Hospital), Shreyans Gandhi(King's College Hospital), Shireen Kassam, Robin Ireland(King's College Hospital NHS Foundation Trust), Judith Marsh(University College Hospital), Charles Manogaran(King's College Hospital), Ghulam J. Mufti(King's College London), Joanna Large(King's College Hospital)
Cited by 74
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2004|637